IGC logo

IGC
IGC Pharma Inc

30,206
Mkt Cap
$34.67M
Volume
1.00
52W High
$0.4985
52W Low
$0.2525
PE Ratio
-4.70
IGC Fundamentals
Price
$0.377
Prev Close
$0.3794
Open
$0.3745
50D MA
$0.4046
Beta
0.49
Avg. Volume
715,776.90
EPS (Annual)
-$0.0931
P/B
5.22
Rev/Employee
$18,157.14
Loading...
Loading...
News
all
press releases
News Placeholder
IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates
IGC Pharma, Inc. (IGC) delivered earnings and revenue surprises of +33.33% and -0.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates
Hyperfine (HYPR) delivered earnings and revenue surprises of 0.00% and -7.03%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Verrica Pharmaceuticals Inc. (VRCA) Q2 Earnings and Revenues Beat Estimates
Verrica Pharmaceuticals (VRCA) delivered earnings and revenue surprises of +102.86% and +154.04%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
IGC Pharma, Inc. (IGC) Reports Q4 Loss, Beats Revenue Estimates
IGC Pharma, Inc. (IGC) delivered earnings and revenue surprises of +50.00% and +6.45%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago

Latest IGC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.